Skip to content

Clinical, serological, pathological features and the response to treatment of autoimmune liver disease: a case records based retrospective study

Clinical, serological, pathological features and the response to treatment of autoimmune liver disease: a case records based retrospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019712
Enrollment
Unknown
Registered
2018-11-24
Start date
2018-07-20
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune liver disease

Interventions

Case series:Nil

Sponsors

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 85 Years

Inclusion criteria

Inclusion criteria: AIH was diagnosis by simplified diagnosis critical: (1) The titers of ANA or ASMA = 1:40 are 1 point; (2) ANA or ASMA = 1:80, or LKM = 1:40 or positive soluble liver antibody (SLA) are 2 points, but the maximum points are 2 points; (3) IgG over ULN is 1 point, IgG > 1.10 × ULN is 2 points; (4) histological evidence that is compatible with AIH is 1 point, typical AIH is 2 points; (5) the absence of viral hepatitis is 2 points.[8] The additional points =6 points was probable AIH, and that =7 points was defined AIH. The diagnosis of PBC can be established if two of three objective features are present: serum AMA at titers = 1:40, unexplained elevated ALP = 1.5 times the upper normal value for over 24 weeks and compatible liver histology, specifically nonsupporative cholangitis and interlobular bile duct injury.

Exclusion criteria

Exclusion criteria: (1) combined with drug-induced hepatitis, fatty hepatitis, viral hepatitis; (2) combined with liver cancer; (3) combined pregnancy or lactation; (4) lack of plenty of examination data; (5) the minors.

Design outcomes

Primary

MeasureTime frame
serum biochemistry;the features of immunity;the histology of liver;

Countries

China

Contacts

Public ContactYuhu Song

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

yuhusong@163.com+86 15007187581

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026